This inventor holds 1 USPTO granted patent. Top assignee: B.r.a.h.m.s Gmbh. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Thomas Muller - Innovator in Chronic Kidney Disease Research
Introduction
Thomas Muller is a prominent inventor based in Linz, Austria. He has made significant contributions to the field of chronic kidney disease (CKD) through his innovative research and patented inventions. His work focuses on the development of prognostic biomarkers that can aid in predicting the progression of primary chronic kidney disease.
Latest Patents
Thomas Muller holds a patent for "Prognostic biomarkers for the progression of primary chronic kidney disease." This invention encompasses assays and in vitro methods designed to predict the progression of CKD or to monitor therapy for chronic kidney disease. The patent specifically involves the determination of the levels of ANP and/or ADM or their precursors or fragments.
Career Highlights
Throughout his career, Thomas Muller has been associated with B.R.A.H.M.S GmbH, a company dedicated to advancing medical diagnostics. His work has been instrumental in enhancing the understanding and management of chronic kidney disease, contributing to better patient outcomes.
Collaborations
Thomas Muller has collaborated with notable colleagues in his field, including Benjamin Dieplinger and Barbara Kollerits. These partnerships have fostered a collaborative environment that promotes innovation and research in kidney disease diagnostics.
Conclusion
Thomas Muller is a key figure in the research of chronic kidney disease, with a focus on developing predictive biomarkers. His contributions through patents and collaborations continue to impact the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile